Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: A meta-analysis

Tumor Biology

Volumn 35, Issue 4, 2014, Pages 3627-3639

  Geng, Rui ^a   Song, Fanglong ^a   Yang, Xiao ^a   Sun, Peng ^a   Hu, Junzheng ^a   Zhu, Chunhui ^a   Zhu, Binjie ^a   Fan, Weimin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer risk; CTLA 4; Meta analysis; Polymorphism

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; EMBASE; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; LUNG CANCER; MEDLINE; META ANALYSIS; MOUTH CANCER; PRIORITY JOURNAL; RISK; RISK FACTOR; STATISTICAL ANALYSIS;

CASE-CONTROL STUDIES; CTLA-4 ANTIGEN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; NEOPLASMS; POLYMORPHISM, GENETIC; RISK;

EID: 84898835420     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1480-x     Document Type: Article

References (51)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, Casella DP, et al. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis. 2006;27:1030-7.
3. Ziogas D, Roukos DH. Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol. 2009;16:1771-82.
4. Ghaderi A. Ctla4 gene variants in autoimmunity and cancer: a comparative review. Iran J Immunol. 2011;8:127-49.
5. Srivastava PK, Duan F. Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges. Cancer Immunol Immunother. 2013;62:967-74.
6. Sun T, Zhou Y, Yang M, Hu Z, Tan W, Han X, et al. Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res. 2008;68:7025-34.
7. Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996;271:1734-6.
8. Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Pezeshki AM, Doroudchi M, et al. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat. 2004;86:1-7.
9. Qi P, Ruan CP, Wang H, Zhou FG, Xu XY, Gu X, et al. Ctla-4 +49a>g polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese. Int J Colorectal Dis. 2010;25:39-45.
10. Zhang Y, Zhang J, Deng Y, Tian C, Li X, Huang J, et al. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis. Cancer. 2011;117:4312-24.
11. Wang L, Li D, Fu Z, Li H, Jiang W, Li D. Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. Bmc Cancer. 2007;7:173.
12. Li D, Zhang Q, Xu F, Fu Z, Yuan W, Li D, et al. Association of CTLA-4 gene polymorphisms with sporadic breast cancer risk and clinical features in Han women of northeast china. Mol Cell Biochem. 2012;364:283-90.
13. Su TH, Chang TY, Lee YJ, Chen CK, Liu HF, Chu CC, et al. CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis. 2007;28:1237-40.
14. Castro FA, Haimila K, Sareneva I, Schmitt M, Lorenzo J, Kunkel N, et al. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population - a candidate gene approach. Int J Cancer. 2009;125:1851-8.
15. Pawlak E, Karabon L, Wlodarska-Polinska I, Jedynak A, Jonkisz A, Tomkiewicz A, et al. Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population. Hum Immunol. 2010;71:195-200.
16. Ivansson EL, Juko-Pecirep I, Gyllensten UB. Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer. Gynecol Oncol. 2010;116:544-8.
17. Rahimifar S, Erfani N, Sarraf Z, Ghaderi A. CTLA-4 gene variations may influence cervical cancer susceptibility. Gynecol Oncol. 2010;119:136-9.
18. Li H, Zhou YF, Guo HY, Sun T, Zhang WH, Lin DX. Association between CTLA-4 gene polymorphism and susceptibility to cervical cancer. Zhonghua Zhong Liu Za Zhi. 2011;33:681-4.
19. Jiang L, Luo RY, Zhang W, Wang LR, Wang F, Cheng YX. Single nucleotide polymorphisms of CTLA4 gene and their association with human cervical cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011;28:313-7.
20. Gokhale P, Kerkar S, Tongaonkar H, Salvi V, Mania-Pramanik J. CTLA-4 gene polymorphism at position +49 A>G in exon 1: a risk factor for cervical cancer in Indian women. Cancer Genet. 2013;206:154-61.
21. Khaghanzadeh N, Erfani N, Ghayumi MA, Ghaderi A. CTLA4 gene variations and haplotypes in patients with lung cancer. Cancer Genet Cytogenet. 2010;196:171-4.
22. Song B, Liu Y, Liu J, Song X, Wang Z, Wang M, et al. CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis. Respiration. 2011;82:439-44.
23. Karabon L, Pawlak E, Tomkiewicz A, Jedynak A, Passowicz-Muszynska E, Zajda K, et al. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer. Hum Immunol. 2011;72:947-54.
24. Hou R, Cao B, Chen Z, Li Y, Ning T, Li C, et al. Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer. Mol Biol Rep. 2010;37:515-20.
25. Liu Y, He Z, Feng D, Shi G, Gao R, Wu X, et al. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. Dna Cell Biol. 2011;30:1051-5.
26. Cheng XL, Ning T, Xu CQ, Li Y, Zhu BS, Hou FT, et al. Haplotype analysis of CTLA4 gene and risk of esophageal squamous cell carcinoma in Anyang area of China. Hepatogastroenterology. 2011;58:432-7.
27. Erfani N, Razmkhah M, Talei AR, Pezeshki AM, Doroudchi M, Monabati A, et al. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer Genet Cytogenet. 2006;165:114-20.
28. Li H, Fu ZK, Wang LH, Li DL, Wu N, Zhang J, et al. Association of cytotoxic T lymphocyte antigen-4 gene polymorphisms with susceptibility to breast cancer. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008;24:282-4.
29. Monne M, Piras G, Palmas A, Arru L, Murineddu M, Latte G, et al. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma. Am J Hematol. 2004;76:14-8.
30. Piras G, Monne M, Uras A, Palmas A, Murineddu M, Arru L, et al. Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: association with non-Hodgkin's lymphoma. Br J Haematol. 2005;129:784-90.
31. Cheng TY, Lin JT, Chen LT, Shun CT, Wang HP, Lin MT, et al. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. J Clin Oncol. 2006;24:3483-9.
32. Solerio E, Tappero G, Iannace L, Matullo G, Ayoubi M, Parziale A, et al. CTLA4 gene polymorphism in Italian patients with colorectal adenoma and cancer. Dig Liver Dis. 2005;37:170-5.
33. Hadinia A, Hossieni SV, Erfani N, Saberi-Firozi M, Fattahi MJ, Ghaderi A. CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers. J Gastroenterol Hepatol. 2007;22:2283-7.
34. Cozar JM, Romero JM, Aptsiauri N, Vazquez F, Vilchez JR, Tallada M, et al. High incidence of CTLA-4 aa (ct60) polymorphism in renal cell cancer. Hum Immunol. 2007;68:698-704.
35. Dilmec F, Ozgonul A, Uzunkoy A, Akkafa F. Investigation of CTLA-4 and CD28 gene polymorphisms in a group of Turkish patients with colorectal cancer. Int J Immunogenet. 2008;35:317-21.
36. Wong YK, Chang KW, Cheng CY, Liu CJ. Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma. J Oral Pathol Med. 2006;35:51-4.
37. Kammerer PW, Toyoshima T, Schoder F, Kammerer P, Kuhr K, Brieger J, et al. Association of T-cell regulatory gene polymorphisms with oral squamous cell carcinoma. Oral Oncol. 2010;46:543-8.
38. Bharti V, Mohanti BK, Das SN. Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk north Indian population. Hum Immunol. 2013;74:348-52.
39. Mahajan R, El-Omar EM, Lissowska J, Grillo P, Rabkin CS, Baccarelli A, et al. Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population. Jpn J Clin Oncol. 2008;38:626-33.
40. Hu L, Liu J, Chen X, Zhang Y, Liu L, Zhu J, et al. CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers-hepatocellular carcinoma and cervical cancer. Hum Immunol. 2010;71:888-91.
41. Gu X, Qi P, Zhou F, Ji Q, Wang H, Dou T, et al. Gao C: +49G>A polymorphism in the cytotoxic t-lymphocyte antigen-4 gene increases susceptibility to hepatitis b-related hepatocellular carcinoma in a male Chinese population. Hum Immunol. 2010;71:83-7.
42. Perez-Garcia A, De la Camara R, Roman-Gomez J, Jimenez-Velasco A, Encuentra M, Nieto JB, et al. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood. 2007;110:461-7.
43. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol. 2006;24:65-97.
44. Nirschl CJ, Drake CG: Molecular pathways: co-expression of immune checkpoint molecules: signaling pathways and implications for cancer immunotherapy. Clin Cancer Res. 2013;19:4917-24.
45. Zhou G, Levitsky H. Towards curative cancer immunotherapy: overcoming posttherapy tumor escape. Clin Dev Immunol. 2012;2012:124187.
46. Sun T, Hu Z, Shen H, Lin D. Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4 and cancer: the dialectical nature of subtle human immune dysregulation. Cancer Res. 2009;69:6011-4.
47. Mao HT, Wang XB, Zhang L, Gu HT. Studies on the genetic pathogenesis of myasthenia gravis caused by CTLA-4 gene polymorphism. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004;21:574-8.
48. Jones KA, Kadonaga JT, Rosenfeld PJ, Kelly TJ, Tjian R. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell. 1987;48:79-89.
49. Bouqbis L, Izaabel H, Akhayat O, Perez-Lezaun A, Calafell F, Bertranpetit J, et al. Association of the CTLA4 promoter region (-1661g allele) with type 1 diabetes in the south Moroccan population. Genes Immunol. 2003;4:132-7.
50. Zahnow CA. CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Res. 2002;4:113-21.
51. Anjos SM, Shao W, Marchand L, Polychronakos C. Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a re-evaluation of the 3' +6230G>A polymorphism. Genes Immunol. 2005;6:305-11.